Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.33) by 89.39 percent. This is a 86.54 percent increase over losses of $(0.26) per share from the same period last year.
US Rail Volumes Flat Amid July Fourth Holiday
The Fourth of July holiday weekend resulted in weaker U.S. volume comparisons year-over-year, but the overall trend for 2021 is still upward for intermodal volumes.
Meanwhile, rail observers anticipate the start of the earnings seasons and the Class I railroads' responses to how they handled supply chain congestion in the second quarter (see below).
